Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

A Verve Therapeutics treatment was found to cut cholesterol levels by more than half—with just one shot. The stock jumped ...

It may be disturbing to characterize human bodies in such commodifying terms, but the unavoidable reality is that human ...

The most high-profile departure will be the biotech’s chief medical officer Maria Koehler, M.D., Ph.D. Story Feb. 14 - Spotlight Therapeutics: The San Francisco gene editor has closed its doors.

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

Good morning, today STAT released our annual STATUS List, which features 50 influential people shaping the future of life ...

Engineers at a University of Bristol spin-out company have created a new technology that can move cells without touching them ...

The U.S. health care sector hasn't escaped the tariff and trade wars, as the industry relies on imports to buy everything from medical devices to the garments worn by medical staff.

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up ...

vice president of business development at Clearmind Medicine (CMND), a psychedelic pharmaceutical biotech company focused on development of therapeutics to solve underserved health problems.